Results 221 to 230 of about 85,355 (254)
Some of the next articles are maybe not open access.
New England Journal of Medicine, 2016
Ductal carcinoma in situ (DCIS) represents a growing health challenge with increasing numbers of cases detected through breast screening programmes. It is unclear exactly what factors contribute to the pathogenesis of DCIS and its progression to invasive cancer.
Andrea L. Merrill +2 more
+4 more sources
Ductal carcinoma in situ (DCIS) represents a growing health challenge with increasing numbers of cases detected through breast screening programmes. It is unclear exactly what factors contribute to the pathogenesis of DCIS and its progression to invasive cancer.
Andrea L. Merrill +2 more
+4 more sources
Surgical Clinics of North America, 2013
Management of ductal carcinoma in situ (DCIS) has evolved from radical surgery to the option of a more minimally invasive approach. Data show that breast conservation surgery performed with administration of radiotherapy, like mastectomy, is feasible and safe.
openaire +2 more sources
Management of ductal carcinoma in situ (DCIS) has evolved from radical surgery to the option of a more minimally invasive approach. Data show that breast conservation surgery performed with administration of radiotherapy, like mastectomy, is feasible and safe.
openaire +2 more sources
EMC - Ginecología-Obstetricia, 2021
Resumen El carcinoma ductal in situ (CDIS) se define como una proliferacion de celulas malignas en los conductos galactoforos, sin que atraviesen la membrana basal. El CDIS representa alrededor el 10-15% del conjunto de los canceres mamarios. Su tratamiento tiene por objetivo prevenir el desarrollo de un cancer infiltrante y, a la vez, evitar un ...
C. Mathelin +4 more
openaire +1 more source
Resumen El carcinoma ductal in situ (CDIS) se define como una proliferacion de celulas malignas en los conductos galactoforos, sin que atraviesen la membrana basal. El CDIS representa alrededor el 10-15% del conjunto de los canceres mamarios. Su tratamiento tiene por objetivo prevenir el desarrollo de un cancer infiltrante y, a la vez, evitar un ...
C. Mathelin +4 more
openaire +1 more source
Breast Disease, 2001
Ductal carcinoma in situ (DCIS) has become a predominant pathologic entity with the broad implementation of screening mammography. In the premammographic era, it represented less than 10% of all breast cancers. Although it now occupies as much as 30% of contemporary series, it remains a controversial subject of debate in terms of its management.
openaire +2 more sources
Ductal carcinoma in situ (DCIS) has become a predominant pathologic entity with the broad implementation of screening mammography. In the premammographic era, it represented less than 10% of all breast cancers. Although it now occupies as much as 30% of contemporary series, it remains a controversial subject of debate in terms of its management.
openaire +2 more sources
Tamoxifen in Ductal Carcinoma In Situ
Seminars in Oncology, 2006The widespread adoption of screening mammography has resulted in an increased incidence of ductal carcinoma in situ (DCIS), which now accounts for 20% to 30% of new breast cancer diagnoses. Despite treatment with combined lumpectomy and radiation therapy, up to 15% of women will experience an ipsilateral breast recurrence, with 50% of these recurrences
openaire +2 more sources
Ugeskrift for laeger, 2019
Ductal carcinoma in situ (DCIS) is a premalignant lesion in the breast. It is often asymptomatic and diagnosed by screening mammography. DCIS is treated in line with low-risk invasive breast cancer including mastectomy or breast-conserving treatment plus radiotherapy, implicating a risk of both physical and psychological side effects. Since only a part
Marica, Skaar +3 more
openaire +1 more source
Ductal carcinoma in situ (DCIS) is a premalignant lesion in the breast. It is often asymptomatic and diagnosed by screening mammography. DCIS is treated in line with low-risk invasive breast cancer including mastectomy or breast-conserving treatment plus radiotherapy, implicating a risk of both physical and psychological side effects. Since only a part
Marica, Skaar +3 more
openaire +1 more source
2008
A. Epidemiology and Risk Factors. Ductal carcinoma in situ (DCIS) is a form of noninvasive breast cancer which usually affects women in their sixth decade of life. The disease is characterized by a proliferation of malignant ductal epithelial cells without microscopic invasion through the basement membrane.
openaire +2 more sources
A. Epidemiology and Risk Factors. Ductal carcinoma in situ (DCIS) is a form of noninvasive breast cancer which usually affects women in their sixth decade of life. The disease is characterized by a proliferation of malignant ductal epithelial cells without microscopic invasion through the basement membrane.
openaire +2 more sources
Presse medicale (Paris, France : 1983), 2003
Presently representing 15 to 30% of new cases of breast cancer, ductal carcinomas in situ do not have specific epidemiological characteristics. The age at which they occur is between 49 and 54 years.The diagnosis is evoked primarily when confronted with an area of micro-calcifications discovered on a mammography.
Anne, de Roquancourt +4 more
openaire +1 more source
Presently representing 15 to 30% of new cases of breast cancer, ductal carcinomas in situ do not have specific epidemiological characteristics. The age at which they occur is between 49 and 54 years.The diagnosis is evoked primarily when confronted with an area of micro-calcifications discovered on a mammography.
Anne, de Roquancourt +4 more
openaire +1 more source
Noncalcified Ductal Carcinoma In Situ (DCIS): Rate and Predictors of Upgrade to Invasive Carcinoma
Academic Radiology, 2021Manisha Bahl, Leslie R Lamb
exaly